Faisal Alrumaih
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Faisal Alrumaih has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Areej Alenzi
Department of Infection Control and Public Health, Regional Laboratory in Northern Border Region, Arar 73211, Saudi Arabia
2 shared publications - Atheer Assiri
Department of Pharmacy, Armed Forces Hospital Southern Region, Mushait 62562, Saudi Arabia
2 shared publications - Bashayr Abdullah
Department of Pharmacy, Maternity and Children Hospital in Rafha, Rafha 76312, Saudi Arabia
2 shared publications - Hanan Haif
Department of Pharmacy, Maternity and Children Hospital in Rafha, Rafha 76312, Saudi Arabia
2 shared publications - Jawaher Mubarak
Department of Pharmacy, Maternity and Children Hospital in Rafha, Rafha 76312, Saudi Arabia
2 shared publications - Maali Ramadan
Department of Pharmacy, Maternity and Children Hospital in Rafha, Rafha 76312, Saudi Arabia
2 shared publications
Latest Publications
- Open Access
- 14 January 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (1) , 84
RETRACTED: Kanan et al. Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward. Antibiotics 2023, 12, 1504
The journal retracts the article “Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward”
- 14 January 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (1) , 84
Open AccessRETRACTED: Kanan et al. Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward. Antibiotics 2023, 12, 1504
The journal retracts the article “Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward”
- Open Access
- 2 October 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (10) , 1504
RETRACTED: Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward
Antibiotic overuse poses a critical global health concern, especially in low- and middle-income countries (LMICs) where access to quality healthcare and effective regulatory frameworks often fall short. This issue necessitates a thorough examination of the factors contributing to antibiotic overuse in LMICs, including weak healthcare infrastructure, limited access to quality services, and deficiencies in diagnostic capabilities. To address these challenges, regulatory frameworks should be implemented to restrict non-prescription sales, and accessible point-of-care diagnostic tools must be emphasized. Furthermore, the establishment of effective stewardship programs, the expanded use of vaccines, and the promotion of health systems, hygiene, and sanitation are all crucial components in combating antibiotic overuse. A comprehensive approach that involves collaboration among healthcare professionals, policymakers, researchers, and educators is essential for success. Improving healthcare infrastructure, enhancing access to quality services, and strengthening diagnostic capabilities are paramount. Equally important are education and awareness initiatives to promote responsible antibiotic use, the implementation of regulatory measures, the wider utilization of vaccines, and international cooperation to tackle the challenges of antibiotic overuse in LMICs.
- 2 October 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (10) , 1504
Open AccessRETRACTED: Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward
Antibiotic overuse poses a critical global health concern, especially in low- and middle-income countries (LMICs) where access to quality healthcare and effective regulatory frameworks often fall short. This issue necessitates a thorough examination of the factors contributing to antibiotic overuse in LMICs, including weak healthcare infrastructure, limited access to quality services, and deficiencies in diagnostic capabilities. To address these challenges, regulatory frameworks should be implemented to restrict non-prescription sales, and accessible point-of-care diagnostic tools must be emphasized. Furthermore, the establishment of effective stewardship programs, the expanded use of vaccines, and the promotion of health systems, hygiene, and sanitation are all crucial components in combating antibiotic overuse. A comprehensive approach that involves collaboration among healthcare professionals, policymakers, researchers, and educators is essential for success. Improving healthcare infrastructure, enhancing access to quality services, and strengthening diagnostic capabilities are paramount. Equally important are education and awareness initiatives to promote responsible antibiotic use, the implementation of regulatory measures, the wider utilization of vaccines, and international cooperation to tackle the challenges of antibiotic overuse in LMICs.